GM adds 7 years to Israel commitment

General Motors has spent $334 million since the two signed their first agreement in May 2001. In 2005 alone, the company bought $102m. from Israeli suppliers, far exceeding its obligations of $586,272 for the year.

By AVI KRAWITZ
August 16, 2006 07:27

 
X

Dear Reader,
As you can imagine, more people are reading The Jerusalem Post than ever before. Nevertheless, traditional business models are no longer sustainable and high-quality publications, like ours, are being forced to look for new ways to keep going. Unlike many other news organizations, we have not put up a paywall. We want to keep our journalism open and accessible and be able to keep providing you with news and analyses from the frontlines of Israel, the Middle East and the Jewish World.

As one of our loyal readers, we ask you to be our partner.

For $5 a month you will receive access to the following:

  • A user experience almost completely free of ads
  • Access to our Premium Section
  • Content from the award-winning Jerusalem Report and our monthly magazine to learn Hebrew - Ivrit
  • A brand new ePaper featuring the daily newspaper as it appears in print in Israel

Help us grow and continue telling Israel’s story to the world.

Thank you,

Ronit Hasin-Hochman, CEO, Jerusalem Post Group
Yaakov Katz, Editor-in-Chief

UPGRADE YOUR JPOST EXPERIENCE FOR 5$ PER MONTH Show me later

The Ministry of Industry, Trade and Labor said Tuesday it has extended its industrial cooperation program with General Motors Corp. whereby the car maker has committed to buy from Israeli suppliers for another seven years. General Motors has spent $334 million since the two signed their first agreement in May 2001. In 2005 alone, the company bought $102m. from Israeli suppliers, far exceeding its obligations of $586,272 for the year.

Join Jerusalem Post Premium Plus now for just $5 and upgrade your experience with an ads-free website and exclusive content. Click here>>

Related Content

The Teva Pharmaceutical Industries
April 30, 2015
Teva doubles down on Mylan, despite rejection

By GLOBES, NIV ELIS